The Increasing Incidence of IBD and the Use of Biosimilars -

The Increasing Incidence of IBD and the Use of Biosimilars

Listen now

Description

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Shubha Bhat, PharmD Fortunately, there are a lot of studies that have evaluated biosimilars in inflammatory bowel disease (IBD), and those all confirmed that biosimilars are safe, effective, and do not result in worsening patient outcomes. But are we using biosimilars enough in the treatment of IBD? Dive in with Dr. Mary Katherine Cheeley as she speaks with Dr. Shubha Bhat, Clinical Pharmacist in the Digestive Disease Institute at the Cleveland Clinic.

More Episodes

See all »

Elderly Patients with IBD: Management Strategies and Care

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David P. Hudesman, MD There’s been an increase in the elderly irritable bowel disease (IBD) population, and it’s estimated that a third of our overall IBD population will soon be over the age of 60. When managing and diagnosing these...

Published 05/16/24

GI Insights

Published 05/16/24

Educating Gastrointestinal Patients About the Benefits of Vaccination

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Francis Farraye, MD Patients with inflammatory bowel disease (IBD) have an increased risk of developing infections, and some may be preventable with a vaccine. Approximately 70 percent of patients with ulcerative colitis or Crohn’s...

Published 05/01/24